• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扩张型心肌病患者中的抗线粒体抗体。

Anti-mitochondrial Antibodies in Patients with Dilated Cardiomyopathy.

机构信息

Department of Cardiovascular Medicine, Fukushima Medical University, Japan.

Department of Pulmonary Hypertension, Fukushima Medical University, Japan.

出版信息

Intern Med. 2021;60(2):201-208. doi: 10.2169/internalmedicine.5422-20. Epub 2021 Jan 15.

DOI:10.2169/internalmedicine.5422-20
PMID:33456024
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7872813/
Abstract

Objective It has been reported that anti-mitochondrial antibodies (AMAs) recognize mitochondrial antigens and are associated with some diseases involving multiple organs, such as primary biliary cholangitis, Sjögren syndrome, Hashimoto's thyroiditis, systemic sclerosis, interstitial pneumoniae, dilated cardiomyopathy, and tubulointerstitial nephritis. In the current study, we examined the prevalence of AMAs in patients with dilated cardiomyopathy (DCM) and their clinical characteristics. Methods We enrolled 270 patients with DCM. We measured serum AMAs and analyzed the associated factors. Out of the 270 patients, positive AMAs were detected in 3 patients (1.1%; mean age, 68 years old; 2 men). These three patients had a significantly higher prevalence of primary biliary cholangitis and myopathy and levels of alanine alkaline phosphatase than those who were negative for said antibodies. There were no significant differences in the levels of B-type natriuretic peptide, aspartate transaminase, and left ventricular ejection fraction between these groups of patients. During the follow-up period, two of the three patients died due to respiratory failure. The other patient survived but experienced type II respiratory failure. Conclusion The prevalence of AMAs in 270 DCM patients was only 1.1%, and these patients suffered from respiratory failure.

摘要

目的

据报道,抗线粒体抗体(AMAs)可识别线粒体抗原,并与一些涉及多个器官的疾病相关,如原发性胆汁性胆管炎、干燥综合征、桥本甲状腺炎、系统性硬化症、间质性肺炎、扩张型心肌病和肾小管间质性肾炎。在本研究中,我们检测了扩张型心肌病(DCM)患者AMA 的患病率及其临床特征。

方法

我们纳入了 270 例 DCM 患者。我们测量了血清 AMA,并分析了相关因素。在 270 例患者中,有 3 例(1.1%;平均年龄 68 岁;2 名男性)AMA 阳性。这 3 例患者原发性胆汁性胆管炎和肌病的患病率以及丙氨酸碱性磷酸酶水平显著高于 AMA 阴性患者。这些患者的 B 型利钠肽、天门冬氨酸转氨酶和左心室射血分数水平无显著差异。在随访期间,这 3 例患者中有 2 例因呼吸衰竭而死亡。另一位患者存活,但出现 II 型呼吸衰竭。

结论

在 270 例 DCM 患者中,AMA 的患病率仅为 1.1%,且这些患者发生了呼吸衰竭。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb4e/7872813/1625a16a321e/1349-7235-60-0201-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb4e/7872813/1625a16a321e/1349-7235-60-0201-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb4e/7872813/1625a16a321e/1349-7235-60-0201-g001.jpg

相似文献

1
Anti-mitochondrial Antibodies in Patients with Dilated Cardiomyopathy.扩张型心肌病患者中的抗线粒体抗体。
Intern Med. 2021;60(2):201-208. doi: 10.2169/internalmedicine.5422-20. Epub 2021 Jan 15.
2
Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.经冠状动脉内 CD34+ 干细胞移植治疗非缺血性扩张型心肌病患者:5 年随访结果。
Circ Res. 2013 Jan 4;112(1):165-73. doi: 10.1161/CIRCRESAHA.112.276519. Epub 2012 Oct 12.
3
Dilated cardiomyopathy in a pediatric population: etiology and outcome predictors - a single-center experience.儿科人群中的扩张型心肌病:病因及预后预测因素——单中心经验
Future Cardiol. 2019 Mar;15(2):95-107. doi: 10.2217/fca-2018-0030. Epub 2019 Mar 8.
4
Sex- and age-based differences in the natural history and outcome of dilated cardiomyopathy.扩张型心肌病的自然病史和转归的性别和年龄差异。
Eur J Heart Fail. 2018 Oct;20(10):1392-1400. doi: 10.1002/ejhf.1216. Epub 2018 Jun 3.
5
A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy.一项评估选择性冠状动脉内输注骨髓来源祖细胞对非缺血性扩张型心肌病患者潜在影响的试点试验:非缺血性扩张型心肌病患者祖细胞移植与功能再生增强试点试验的1年最终结果
Circ Heart Fail. 2009 Sep;2(5):417-23. doi: 10.1161/CIRCHEARTFAILURE.109.855023. Epub 2009 Jul 29.
6
[Clinical and genetic characteristics of children with primary dilated cardiomyopathy].[原发性扩张型心肌病患儿的临床及遗传特征]
Zhongguo Dang Dai Er Ke Za Zhi. 2023 Jul 15;25(7):726-731. doi: 10.7499/j.issn.1008-8830.2303077.
7
Dilated cardiomyopathy with re-worsening left ventricular ejection fraction.扩张型心肌病伴左心室射血分数再次恶化。
Heart Vessels. 2019 Jan;34(1):95-103. doi: 10.1007/s00380-018-1214-5. Epub 2018 Jun 25.
8
Right ventricular dilated cardiomyopathy associated with primary biliary cirrhosis.
Eur Heart J. 1991 Nov;12(11):1240-3. doi: 10.1093/eurheartj/12.11.1240.
9
Effect of trimetazidine combined with perindopril on NT-proBNP level in rats with dilated cardiomyopathy.曲美他嗪联合培哚普利对扩张型心肌病大鼠N末端B型利钠肽原水平的影响
Cell Mol Biol (Noisy-le-grand). 2020 May 16;66(2):198-203.
10
Intramuscular injection of human umbilical cord-derived mesenchymal stem cells improves cardiac function in dilated cardiomyopathy rats.肌肉注射人脐带间充质干细胞可改善扩张型心肌病大鼠的心功能。
Stem Cell Res Ther. 2017 Jan 28;8(1):18. doi: 10.1186/s13287-017-0472-y.

引用本文的文献

1
Anti-mitochondrial antibody-positive inflammatory myopathy with multiple arrhythmias resistant to high-dose glucocorticoids and intravenous cyclophosphamide: a case-based review.抗线粒体抗体阳性的炎性肌病合并多种对大剂量糖皮质激素和静脉注射环磷酰胺耐药的心律失常:病例回顾
Clin Rheumatol. 2025 Apr 16. doi: 10.1007/s10067-025-07439-3.
2
Dilated cardiomyopathy with anti-mitochondrial M2 antibody: A case series.伴有抗线粒体M2抗体的扩张型心肌病:病例系列
J Cardiol Cases. 2023 Mar 7;28(1):11-15. doi: 10.1016/j.jccase.2023.02.021. eCollection 2023 Jul.
3
Sick sinus syndrome concomitant with myopathy associated with anti-mitochondrial antibodies: a case report.

本文引用的文献

1
Primary biliary cholangitis in patients with inflammatory bowel disease.原发性胆汁性胆管炎在炎症性肠病患者中的表现。
Clin Res Hepatol Gastroenterol. 2020 Feb;44(1):e5-e9. doi: 10.1016/j.clinre.2019.05.002. Epub 2019 Jun 3.
2
Cardioprotective Effect of the Mitochondrial Unfolded Protein Response During Chronic Pressure Overload.慢性压力超负荷过程中线粒体未折叠蛋白反应的心脏保护作用。
J Am Coll Cardiol. 2019 Apr 16;73(14):1795-1806. doi: 10.1016/j.jacc.2018.12.087.
3
PBC and related extrahepatic diseases.原发性胆汁性胆管炎和相关肝外疾病。
伴有抗线粒体抗体相关肌病的病态窦房结综合征:一例报告
Eur Heart J Case Rep. 2022 Apr 8;7(6):ytac158. doi: 10.1093/ehjcr/ytac158. eCollection 2023 Jun.
4
The Emerging Role of Mitochondrial Dysfunction in the Pathogenesis of Idiopathic Inflammatory Myopathies.线粒体功能障碍在特发性炎性肌病发病机制中的新作用
Rambam Maimonides Med J. 2023 Apr 30;14(2):e0006. doi: 10.5041/RMMJ.10493.
Best Pract Res Clin Gastroenterol. 2018 Jun-Aug;34-35:49-54. doi: 10.1016/j.bpg.2018.05.013. Epub 2018 May 23.
4
Treatment options in myocarditis and inflammatory cardiomyopathy : Focus on i. v. immunoglobulins.心肌炎和炎症性心肌病的治疗选择:聚焦于静脉注射免疫球蛋白
Herz. 2018 Aug;43(5):423-430. doi: 10.1007/s00059-018-4719-x.
5
Eosinophilic myocarditis associated with anti-mitochondrial M2 antibodies: a mechanism underlying the onset of myocarditis.
Eur Heart J. 2018 Oct 1;39(37):3480-3481. doi: 10.1093/eurheartj/ehy246.
6
Cardiac involvement in patients with primary biliary cholangitis: A 14-year longitudinal survey-based study.原发性胆汁性胆管炎患者的心脏受累:一项基于 14 年纵向调查的研究。
PLoS One. 2018 Mar 15;13(3):e0194397. doi: 10.1371/journal.pone.0194397. eCollection 2018.
7
Usefulness of Urinary N-Terminal Fragment of Titin to Predict Mortality in Dilated Cardiomyopathy.肌联蛋白氨基末端片段预测扩张型心肌病死亡率的效用
Am J Cardiol. 2018 May 15;121(10):1260-1265. doi: 10.1016/j.amjcard.2018.01.046. Epub 2018 Feb 12.
8
Liver fibrosis marker, 7S domain of collagen type IV, in patients with pre-capillary pulmonary hypertension.肝纤维化标志物,IV 型胶原 7S 域,在毛细血管前性肺动脉高压患者中。
Int J Cardiol. 2018 May 1;258:269-274. doi: 10.1016/j.ijcard.2018.01.138. Epub 2018 Feb 8.
9
Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement.与抗线粒体抗体相关的炎性肌病:伴有心脏受累的独特表型。
Semin Arthritis Rheum. 2018 Feb;47(4):552-556. doi: 10.1016/j.semarthrit.2017.06.004. Epub 2017 Jun 13.
10
Anti-mitochondrial M2 Antibodies Enhance the Risk of Supraventricular Arrhythmias in Patients with Elevated Hepatobiliary Enzyme Levels.抗线粒体M2抗体增加肝胆酶水平升高患者发生室上性心律失常的风险。
Intern Med. 2017;56(14):1771-1779. doi: 10.2169/internalmedicine.56.8183. Epub 2017 Jul 15.